Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check50 days agoChange DetectedThe website has been updated from version 2.9.7 to 2.10.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
- Check51 days agoChange DetectedThe website has removed the 'Last Update Posted (Estimated)' and now features a definitive 'Last Update Posted' section.SummaryDifference0.0%
- Check53 days agoChange DetectedRecent updates include new dates for July 2024, while previous updates from December 2023 have been removed, indicating a shift in focus to more current information.SummaryDifference0.7%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.